Cardiac‐specific overexpression of Zfp36 mitigated cardiac hypertrophy by inhibiting ferroptosis, whereas Zfp36 deficiency aggravated cardiac hypertrophy by promoting ferroptosis. Here, ZFP36 is linked to cardiac hypertrophy.